Smartleaf Asset Management LLC raised its holdings in shares of Okta, Inc. (NASDAQ:OKTA – Free Report) by 40.2% in the 4th ...

LifeMD Inc (LFMD) reports a 43% revenue increase and unveils plans for new product launches and Medicare offerings amid ...

DarioHealth Corp (DRIO) reports a 32.9% revenue increase and significant B2B2C growth, while aiming for operational breakeven by the end of 2025.

For patients with type 2 diabetes (T2D), glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with a reduced ...

LSU Health Shreveport has announced the Rapides Health Project, which works by providing a free three-month supply of GLP-1 agonists. You may know these by other names, such as Semaglutide, Mounjaro ...

GLP-1 agonists can also come with other unpleasant side effects, like nausea and constipation. Meanwhile, a nimal testing of BRP showed no sign of these side-effects, or muscle loss, perhaps because ...

A new study presented at the American Academy of Orthopedic Surgeons meeting reveals the need to stop taking GLP-1 agonists ...

Increasing access to these effective evidence-based treatments would benefit our society as a whole, not just those impacted ...

Budget hearings are over at the State Capitol, but one particular expense involving a popular weight loss drug has caught the ...

A study presented at the 2025 Annual Meeting of the American Academy of Orthopaedic Surgeons examined the relationship between the patient's last dose of Ozempic, a common GLP-1, and ...

CagriSema is a fixed-dose combination of cagrilintide, a long-acting amylin analogue, and semaglutide, a glucagon-like peptide-1 receptor agonist.

For patients with type 2 diabetes (T2D), glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with a reduced ...